{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:37:39Z","timestamp":1761514659430,"version":"3.40.5"},"reference-count":28,"publisher":"VM Media Group sp. z o.o","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reports of Practical Oncology & Radiotherapy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.rpor.2020.09.015","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T15:05:59Z","timestamp":1601737559000},"page":"943-950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic factors and clinical outcomes after stereotactic radiotherapy for primary lung tumors"],"prefix":"10.5603","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8898-868X","authenticated-orcid":false,"given":"Isabel","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Gagean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Laranja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5247-4759","authenticated-orcid":false,"given":"Tiago","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Cardia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3595","reference":[{"issue":"Feb (1)","key":"10.1016\/j.rpor.2020.09.015_bib0005","first-page":"32","article-title":"Medically inoperable stage I non-small cell lung cancer: Best practices and long-term outcomes","volume":"8","author":"Choi","year":"2019","journal-title":"Transl Lung Cancer Res"},{"issue":"July (20)","key":"10.1016\/j.rpor.2020.09.015_bib0010","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1200\/JCO.2008.21.5681","article-title":"Outcome in a prospective phase II trial of medically inoperable stage I non\u2013small-cell lung cancer patients treated with stereotactic body radiotherapy","volume":"27","author":"Baumann","year":"2009","journal-title":"J Clin Oncol"},{"issue":"Mar (2)","key":"10.1016\/j.rpor.2020.09.015_bib0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cllc.2016.10.006","article-title":"Predictors and patterns of regional recurrence following lung SBRT: A report from the elekta lung research group","volume":"18","author":"Giuliani","year":"2017","journal-title":"Clin Lung Cancer"},{"issue":"July (suppl_4)","key":"10.1016\/j.rpor.2020.09.015_bib0020","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","article-title":"ESMO Guidelines Committee. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Postmus","year":"2017","journal-title":"Ann Oncol"},{"issue":"Feb (4)","key":"10.1016\/j.rpor.2020.09.015_bib0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/cncr.31196","article-title":"Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review","volume":"124","author":"Tandberg","year":"2018","journal-title":"Cancer"},{"issue":"Feb (4)","key":"10.1016\/j.rpor.2020.09.015_bib0030","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cncr.30375","article-title":"Multi-institutional experience of stereotactic body radiotherapy for large (\u22655 centimeters) non-small cell lung tumors","volume":"123","author":"Verma","year":"2017","journal-title":"Cancer"},{"issue":"May (15)","key":"10.1016\/j.rpor.2020.09.015_bib0035","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-Cell lung Cancer: Nrg Oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"issue":"Mar (11)","key":"10.1016\/j.rpor.2020.09.015_bib0040","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"issue":"April (5)","key":"10.1016\/j.rpor.2020.09.015_bib0045","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ijrobp.2018.11.051","article-title":"Long-term follow-up on NRG oncology RTOG 0915 (NCCTG N0927): A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung Cancer","volume":"103","author":"Videtic","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Feb (3)","key":"10.1016\/j.rpor.2020.09.015_bib0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"Oct (1)","key":"10.1016\/j.rpor.2020.09.015_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2016.08.015","article-title":"SPACE \u2013 A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC","volume":"121","author":"Nyman","year":"2016","journal-title":"Radiother Oncol"},{"issue":"Nov (2)","key":"10.1016\/j.rpor.2020.09.015_bib0060","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2017.08.029","article-title":"Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy","volume":"125","author":"H\u00f6rner-Rieber","year":"2017","journal-title":"Radiother Oncol"},{"issue":"Sep (3)","key":"10.1016\/j.rpor.2020.09.015_bib0065","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jtcvs.2010.01.046","article-title":"Size matters: A comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)","volume":"140","author":"Dunlap","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"Jan (1)","key":"10.1016\/j.rpor.2020.09.015_bib0070","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1016\/j.prro.2018.09.003","article-title":"Impact of tumor size on local control and pneumonitis after stereotactic body radiation therapy for lung tumors","volume":"9","author":"Parker","year":"2019","journal-title":"Pract Radiat Oncol"},{"issue":"Dec (5)","key":"10.1016\/j.rpor.2020.09.015_bib0075","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2013.08.020","article-title":"The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small lung cancer","volume":"87","author":"Allibhai","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Nov (11)","key":"10.1016\/j.rpor.2020.09.015_bib0080","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1097\/JTO.0000000000000313","article-title":"Lung stereotactic body radiation therapy: Regional nodal failure is not predicted by tumor size","volume":"9","author":"Marwaha","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"June (3)","key":"10.1016\/j.rpor.2020.09.015_bib0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.radonc.2009.02.011","article-title":"Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: Clinical outcome","volume":"91","author":"van der Voort van Zyp","year":"2009","journal-title":"Radiother Oncol"},{"issue":"Nov (3)","key":"10.1016\/j.rpor.2020.09.015_bib0090","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1016\/j.ijrobp.2015.07.1593","article-title":"Marriage and gender: Effect on overall survival in patients treated with lung stereotactic body radiation therapy (SBRT)","volume":"93","author":"Pham","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Oct (7)","key":"10.1016\/j.rpor.2020.09.015_bib0095","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3109\/0284186X.2013.813635","article-title":"Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: An updated retrospective study on local failure and survival rates","volume":"52","author":"Jeppesen","year":"2013","journal-title":"Acta Oncol"},{"issue":"July (2)","key":"10.1016\/j.rpor.2020.09.015_bib0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.296.2.180","article-title":"Women\u2019s susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer","volume":"296","author":"International Early Lung Cancer Action Program Investigators","year":"2006","journal-title":"JAMA"},{"issue":"July (1)","key":"10.1016\/j.rpor.2020.09.015_bib0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2017.05.012","article-title":"ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer","volume":"124","author":"Guckenberger","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2020.09.015_bib0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijrobp.2017.01.040","article-title":"A phase 2 randomized study of 2 stereotactic body radiation therapy regimens for medically inoperable patients with node-negative, peripheral non-small cell lung Cancer","volume":"98","author":"Singh","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Mar (3)","key":"10.1016\/j.rpor.2020.09.015_bib0115","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jtho.2016.11.002","article-title":"A histologic basis for the efficacy of SBRT to the lung","volume":"12","author":"Woody","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"April","key":"10.1016\/j.rpor.2020.09.015_bib0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lungcan.2018.01.021","article-title":"Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer","volume":"118","author":"Baine","year":"2018","journal-title":"Lung Cancer"},{"issue":"June (6)","key":"10.1016\/j.rpor.2020.09.015_bib0125","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/JTO.0000000000000185","article-title":"Primary tumor standardized uptake value measured on F18-fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: Meta-analysis","volume":"9","author":"Na","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"Aug (2)","key":"10.1016\/j.rpor.2020.09.015_bib0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lungcan.2015.05.019","article-title":"FDG-PET Maximum Standardized Uptake Value is Prognostic for Recurrence and Survival after Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer","volume":"89","author":"Khoutek","year":"2015","journal-title":"Lung Cancer"},{"issue":"July","key":"10.1016\/j.rpor.2020.09.015_bib0135","first-page":"1","article-title":"Survival after stereotaxtic radiotherapy in patients with early-stage non-small cell lung cancer","author":"Hansen","year":"2019","journal-title":"Acta Oncol"},{"issue":"Mar (2)","key":"10.1016\/j.rpor.2020.09.015_bib0140","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.cllc.2017.08.002","article-title":"Survival impact of cardiac dose following lung stereotactic body radiotherapy","volume":"19","author":"Wong","year":"2018","journal-title":"Clin Lung Cancer"}],"container-title":["Reports of Practical Oncology & Radiotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136720301395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136720301395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T14:16:14Z","timestamp":1613657774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1507136720301395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1507136720301395"],"URL":"https:\/\/doi.org\/10.1016\/j.rpor.2020.09.015","relation":{},"ISSN":["1507-1367"],"issn-type":[{"type":"print","value":"1507-1367"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors and clinical outcomes after stereotactic radiotherapy for primary lung tumors","name":"articletitle","label":"Article Title"},{"value":"Reports of Practical Oncology & Radiotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpor.2020.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}